14 December 2020 07:00 CET

EQT IX, through Roar BidCo AB, announces a public offer of SEK 220 in cash per share to the shareholders of Recipharm AB (publ) and SEK 1,427,010 in cash per Convertible Bond

#EQT IX #Recipharm

For more information, click here.

Latest news

30 June 2022
Invitation to presentation of EQT AB’s Half-year Report 2022
22 June 2022
EQT Private Equity to sell Facile.it, Italy’s largest online price comparison platform, to Silver Lake
22 June 2022
EQT Private Equity to acquire SPT Labtech, a fast-growing laboratory automation player focused on low-volume liquid handling technology for GBP 650 million from Battery Ventures
14 June 2022
Partnering to accelerate impact
07 June 2022
EQT Private Equity and Mubadala to acquire Envirotainer, the leading global provider of mission-critical biopharma transport services